Treatment of fulminant multiple sclerosis with intravenous cyclophosphamide

Bianca Weinstock Guttman,R. P. Kinkel,Jeffrey A. Cohen,Richard M. Ransohoff,Kathleen M. Schwetz,D. Gogol,M. Namey,Richard A. Rudick

Treatment of fulminant multiple sclerosis with intravenous cyclophosphamide

1997

Bianca Weinstock Guttman
R. P. Kinkel
Jeffrey A. Cohen
Richard M. Ransohoff
Kathleen M. Schwetz
D. Gogol
M. Namey
Richard A. Rudick

BACKGROUNDThe role of intravenous (IV) cyclophosphamide (CTX) for patients with progressive multiple sclerosis (MS) remains controversial, despite numerous controlled and uncontrolled clinical trials.OBJECTIVETo present the results of open label treatment with CTX and intravenous methylprednisolone

Keywords:

Gastroenterology
Physical therapy
Multiple sclerosis
Fulminant
OPEN LABEL TREATMENT
Immunosuppression
Methylprednisolone
Progressive multiple sclerosis
Cyclophosphamide
Medicine
Diabetes mellitus
Internal medicine
intravenous methylprednisolone
intravenous cyclophosphamide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations